Diabetes and kidney disease are epidemics in the general population, with CKD prevalence ranging from 10% to 12%. Diabetes and hypertension account for 75% of all chronic kidney disease cases. Kidney disease affects more than 33% of diabetic patients. Diabetic patients can develop kidney disease as a result of diabetes or non-diabetic reasons. Diabetic Kidney Disease is largely preventable if detected early. Certain anti-diabetic medications belonging to the SGLT-2 inhibitors group and angiotensin receptor blocker pharmaceuticals are particular drugs used to minimize protein excretion in the urine and slow the course of kidney impairment in diabetic patients. Both medications belong to the cardioprotective and renoprotective pharmacological classes. We offer complete treatment. For more details please contact us! 9811459842
